SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043230
Filing Date
2021-08-11
Accepted
2021-08-11 08:16:15
Documents
51
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rapt-10q_20210630.htm   iXBRL 10-Q 2402718
2 EX-31.1 rapt-ex311_7.htm EX-31.1 18160
3 EX-31.2 rapt-ex312_8.htm EX-31.2 18160
4 EX-32.1 rapt-ex321_6.htm EX-32.1 14777
  Complete submission text file 0001564590-21-043230.txt   6534711

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rapt-20210630.xsd EX-101.SCH 32360
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rapt-20210630_cal.xml EX-101.CAL 37766
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rapt-20210630_def.xml EX-101.DEF 118941
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rapt-20210630_lab.xml EX-101.LAB 277534
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rapt-20210630_pre.xml EX-101.PRE 208529
10 EXTRACTED XBRL INSTANCE DOCUMENT rapt-10q_20210630_htm.xml XML 1114059
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38997 | Film No.: 211162051
SIC: 2834 Pharmaceutical Preparations